Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock
(WorldNews Business)

SAN FRANCISCO--(BUSINESS WIRE)--Feb 19, 2020-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common stock at a price to the public of $28.00 per share. The gross proceeds of the offering to Twist before deducting the underwriting discount and commissions and estimated offering expenses, and assuming no exercise of the underwriters´ option to purchase additional shares, are expected to be approximately $130.0 million. Twist has granted the underwriters an option for a period of 30 days to...